Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial.

[1]  L. Okell,et al.  Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial. , 2013, The Journal of infectious diseases.

[2]  S. Meshnick,et al.  Nonrandomized Controlled Trial of Artesunate plus Sulfadoxine-Pyrimethamine with or without Primaquine for Preventing Posttreatment Circulation of Plasmodium falciparum Gametocytes , 2013, Antimicrobial Agents and Chemotherapy.

[3]  Martin Walker,et al.  Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection , 2013, eLife.

[4]  T. Bousema,et al.  Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda , 2013, BMJ Open.

[5]  W. Hawley,et al.  The effect of primaquine on gametocyte development and clearance in the treatment of uncomplicated falciparum malaria with dihydroartemisinin-piperaquine in South sumatra, Western indonesia: an open-label, randomized, controlled trial. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  N. White.  Primaquine to prevent transmission of falciparum malaria. , 2013, The Lancet. Infectious diseases.

[7]  T. Bousema,et al.  Can field-based mosquito feeding assays be used for evaluating transmission-blocking interventions? , 2013, Trends in parasitology.

[8]  L. Luzzatto,et al.  Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common , 2012, Malaria Journal.

[9]  Geneva,et al.  Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting , 2012, Malaria Journal.

[10]  Anand P. Patil,et al.  G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map , 2012, PLoS medicine.

[11]  P. Garner,et al.  Primaquine for reducing Plasmodium falciparum transmission. , 2012, The Cochrane database of systematic reviews.

[12]  E. Arango,et al.  Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia. , 2012, Acta tropica.

[13]  S. Donegan,et al.  Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. , 2012, The Cochrane database of systematic reviews.

[14]  T. Wellems,et al.  The threat of artemisinin-resistant malaria. , 2011, The New England journal of medicine.

[15]  Teun Bousema,et al.  Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.

[16]  Elizabeth Ashley,et al.  Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial , 2010, The Lancet. Infectious diseases.

[17]  T. Bousema,et al.  In Tanzania, Hemolysis after a Single Dose of Primaquine Coadministered with an Artemisinin Is Not Restricted to Glucose-6-Phosphate Dehydrogenase-Deficient (G6PD A−) Individuals , 2010, Antimicrobial Agents and Chemotherapy.

[18]  T. Bousema,et al.  Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission , 2009, PloS one.

[19]  R. Price,et al.  Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity , 2008, Malaria Journal.

[20]  P. Rosenthal,et al.  Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda , 2008, Malaria Journal.

[21]  D. Durrheim,et al.  Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. , 2008, The Journal of infectious diseases.

[22]  O. Sabot,et al.  A new global malaria eradication strategy , 2008, The Lancet.

[23]  T. Bousema,et al.  Primaquine Clears Submicroscopic Plasmodium falciparum Gametocytes that Persist after Treatment with Sulphadoxine-Pyrimethamine and Artesunate , 2007, PloS one.

[24]  R. Sauerwein,et al.  Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. , 2007, The American journal of tropical medicine and hygiene.

[25]  A. Muñoz,et al.  Use of area under the curve to characterize transmission potential after antimalarial treatment. , 2006, The American journal of tropical medicine and hygiene.

[26]  Umberto D'Alessandro,et al.  Variation in malaria transmission intensity in seven sites throughout Uganda. , 2006, The American journal of tropical medicine and hygiene.

[27]  R. Hallett,et al.  Chloroquine/Sulphadoxine-Pyrimethamine for Gambian Children with Malaria: Transmission to Mosquitoes of Multidrug-Resistant Plasmodium falciparum , 2006, PLoS clinical trials.

[28]  Petra Schneider,et al.  Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. , 2006, The Journal of infectious diseases.

[29]  C. Drakeley,et al.  Reduction of Malaria Transmission to Anopheles Mosquitoes with a Six-Dose Regimen of Co-Artemether , 2005, PLoS medicine.

[30]  Petra Schneider,et al.  Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. , 2004, Molecular and biochemical parasitology.

[31]  Nicholas J. White,et al.  Activities of Artesunate and Primaquine against Asexual- and Sexual-Stage Parasites in Falciparum Malaria , 2004, Antimicrobial Agents and Chemotherapy.

[32]  C. Drakeley,et al.  Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short‐lived reduction in infectiousness for mosquitoes , 2004, Tropical medicine & international health : TM & IH.

[33]  C. Drakeley,et al.  Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. , 2001, The Journal of infectious diseases.

[34]  Y. Fu,et al.  The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. , 1994, Chinese medical journal.

[35]  Margaret Mitchell,et al.  Brief Report: Special Modifications of the Fluorescent Screening Method for Glucose-6-Phosphate Dehydrogenase Deficiency , 1968 .

[36]  M. Mackerras,et al.  Observations on the action of quinine, atebrin and plasmoquine on the gametocytes of Plasmodium falciparum. , 1949, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[37]  J. Baird,et al.  Consideration of ethics in primaquine therapy against malaria transmission. , 2011, Trends in parasitology.

[38]  Andrea K. Knittel,et al.  Open Access RESEARCH , 2010 .

[39]  Organización Mundial de la Salud.  Guidelines for the treatment of malaria , 2010 .

[40]  A. Tarlov,et al.  Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report. , 1960, Bulletin of the World Health Organization.

[41]  M. Cappellini,et al.  Glucose-6-phosphate dehydrogenase defi ciency , 2022 .